Koyfin Home > Directory > Health Care > Abeona Therapeutics > Levered Free Cash Flow (FCF)

Abeona Therapeutics Levered Free Cash Flow (FCF) Chart (ABEO)

Abeona Therapeutics annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Abeona Therapeutics Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-5m a -150.54% increase of 8m year over year
  • Abeona Therapeutics Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-14m a -198.33% increase of 29m year over year
  • Abeona Therapeutics Annual Levered Free Cash Flow (FCF) for 2019 was $-21m a -49.92% increase of 10m from 2018
  • Abeona Therapeutics Annual Levered Free Cash Flow (FCF) for 2018 was $-31m a 45.48% decrease of -14m from 2017
  • Abeona Therapeutics Annual Levered Free Cash Flow (FCF) for 2017 was $-17m a 103.60% decrease of -17m from 2016
Other Cash Flow Metrics:
  • Abeona Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-9m a 41.08% decrease of -4m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO Levered Free Cash Flow (FCF) Data

06/2020$-5m
03/2020$-8m
12/2019$12m
09/2019$-13m
06/2019$-10m
03/2019$-9m
12/2018$-11m
09/2018$-5m
06/2018$-9m
03/2018$-6m

Annual ABEO Levered Free Cash Flow (FCF) Data

2019$-21m
2018$-31m
2017$-17m
2016$1m
2015$-3m
2014$-7m
2013$2m
2012$-5m
2011$-2m
2010$-4m